_____________________
Presentation
The “Biotherapies – Biotherapies by nucleic acid vectorization” team is developing 3 main lines of research:
* Development of innovative strategies for RNA delivery, small interfering RNAs or mRNAs.
* Pharmacological evaluation of new therapeutic strategies, mainly in the fields of inflammatory diseases, hepatic fibrosis and cancer. fibrosis or cancer.
* Development of tumor-penetrating and tumor-interfering peptides (TP and IP), capable of specifically penetrating tumor cells, without any effect on healthy cells, and blocking the interaction between two proteins deregulated during tumor transformation.
May 2026 – Anna Schreiber, a doctoral student at UTCBS, will participate in the Pint of Science festival
May 2026 – Anna Schreiber, a doctoral student at UTCBS, will participate in the Pint of Science festival Lire la suite May 2026 – Anna Schreiber, a doctoral student at UTCBS, will participate in the Pint of Science festival
April 2026 – The second conference on lipid nanoparticles for RNA delivery was a resounding success
The second conference on lipid nanoparticles for RNA delivery was a resounding success Lire la suite April 2026 – The second conference on lipid nanoparticles for RNA delivery was a resounding success
April 2026 – 2nd Meeting on Lipid Nanoparticles for RNA Delivery
Nathalie Mignet and her team, in collaboration with the French Society of Nanomedicine, are organizing the 2nd Symposium on Lipid Nanoparticles for RNA Delivery on Friday, April 10, 2026 Lire la suite April 2026 – 2nd Meeting on Lipid Nanoparticles for RNA Delivery
UTCBS’s Commitment to Environmental Responsibility
On March 23, 2026, the first Eco-Correspondents Day was held at Paris Cité University! Lire la suite UTCBS’s Commitment to Environmental Responsibility